CV Sciences Inc (CVSI)

[Deetew]

Cannabis has an untenable schedule I status.

See here why.

Source:
FDA Briefing Document on CBD

"Based on clinical experimental data, CBD does not appear to have abuse potential:

• In a Phase 1 human abuse potential study with CBD, there were some slight abuse-related signals from the positive subjective measures, but these responses were close to being within the acceptable placebo range and were much lower than the abuse-related signals produced by the positive control drugs with known abuse potential (dronabinol and alprazolam). CBD produced a low level of euphoria-related adverse events (AEs), but this was much lower than that produced by dronabinol and did not predict positive subjective responses.
• There were no euphoria-related AEs in other Phase 1 clinical studies conducted with CBD in a non-patient population that would be indicative of abuse potential. Drugs that have abuse potential typically produce euphoria-related AEs in clinical studies. Phase 2 clinical studies with CBD were not assessed for euphoria related AEs because the antiepileptic medication patients were also taking can have known abuse potential that would confound the evaluation.

55
CSS Background Document
Cannabidiol NDA 210,365

Therefore, an overall assessment of the abuse-related data from preclinical and clinical studies leads to the finding that CBD has negligible abuse potential."

Regardless of whether it gets rescheduled today or not is a non-issue. The big issue at stake here is that CBD was found to have practically no potential for abuse.


Source:
Schedule I Status Definition

"This is the list of Schedule I drugs as defined by the United States Controlled Substances Act.[1] The following findings are required for drugs to be placed in this schedule:[2]

1. The drug or other substance has a high potential for abuse.

2. The drug or other substance has no currently accepted medical use in treatment in the United States.

3. There is a lack of accepted safety for use of the drug or other substance under medical supervision."

All 3 above are untenable based on the FDA's findings from the FDA's website in regards to CBD. Marijuana/cannabis's Schedule I status is therefore also untenable. The DEA has no choice but to remove cannabis from schedule I due to this conflict of interest presented here. Have a nice day.